X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs ORCHID PHARMA LTD - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD ORCHID PHARMA LTD ALEMBIC LTD/
ORCHID PHARMA LTD
 
P/E (TTM) x 133.9 -0.6 - View Chart
P/BV x 5.0 0.4 1,142.7% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ALEMBIC LTD   ORCHID PHARMA LTD
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
ORCHID PHARMA LTD
Sep-13
ALEMBIC LTD/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs53194 27.2%   
Low Rs2935 83.7%   
Sales per share (Unadj.) Rs4.7276.5 1.7%  
Earnings per share (Unadj.) Rs8.8-79.2 -11.1%  
Cash flow per share (Unadj.) Rs9.0-43.5 -20.7%  
Dividends per share (Unadj.) Rs0.150-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs27.753.9 51.4%  
Shares outstanding (eoy) m267.0370.45 379.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x8.70.4 2,100.1%   
Avg P/E ratio x4.7-1.4 -323.7%  
P/CF ratio (eoy) x4.6-2.6 -173.0%  
Price / Book Value ratio x1.52.1 69.7%  
Dividend payout %1.70-   
Avg Mkt Cap Rs m10,9628,067 135.9%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m2382,527 9.4%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m1,26019,477 6.5%  
Other income Rs m264407 64.8%   
Total revenues Rs m1,52419,884 7.7%   
Gross profit Rs m831,103 7.5%  
Depreciation Rs m612,519 2.4%   
Interest Rs m05,227 0.0%   
Profit before tax Rs m285-6,236 -4.6%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32511 -6.3%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m2,343-5,580 -42.0%  
Gross profit margin %6.65.7 116.1%  
Effective tax rate %2.12.0 106.6%   
Net profit margin %185.9-28.7 -648.8%  
BALANCE SHEET DATA
Current assets Rs m1,68911,014 15.3%   
Current liabilities Rs m48632,060 1.5%   
Net working cap to sales %95.4-108.1 -88.3%  
Current ratio x3.50.3 1,011.1%  
Inventory Days Days21795 228.7%  
Debtors Days Days8134 241.5%  
Net fixed assets Rs m1,62429,440 5.5%   
Share capital Rs m534705 75.8%   
"Free" reserves Rs m5,9602,043 291.8%   
Net worth Rs m7,4043,800 194.8%   
Long term debt Rs m1049,018 1.2%   
Total assets Rs m8,01046,510 17.2%  
Interest coverage x950.7-0.2 -492,267.1%   
Debt to equity ratio x02.4 0.6%  
Sales to assets ratio x0.20.4 37.6%   
Return on assets %29.3-0.8 -3,848.6%  
Return on equity %31.6-146.9 -21.5%  
Return on capital %31.3-3.7 -837.8%  
Exports to sales %2.937.9 7.8%   
Imports to sales %28.922.6 127.6%   
Exports (fob) Rs m377,378 0.5%   
Imports (cif) Rs m3644,406 8.3%   
Fx inflow Rs m377,513 0.5%   
Fx outflow Rs m3655,649 6.5%   
Net fx Rs m-3281,865 -17.6%   
CASH FLOW
From Operations Rs m3461,682 20.6%  
From Investments Rs m-48-9,860 0.5%  
From Financial Activity Rs m-3016,644 -4.5%  
Net Cashflow Rs m-3-1,535 0.2%  

Share Holding

Indian Promoters % 64.0 32.3 198.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.6 4.3%  
FIIs % 9.7 3.3 293.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 26.1 55.3 47.2%  
Shareholders   54,701 84,811 64.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare ALEMBIC LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Breaches 36,000 Mark; ONGC Nears 52-Week High(Closing)

The NSE Nifty on Tuesday sailed past the 11,000 mark, while the BSE Sensex breached the 36,000 level for the first time after an IMF report showed India was set to regain.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jan 23, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS